Mitesco Stock Net Income

MITI Stock  USD 0.05  0  2.20%   
As of the 1st of February, Mitesco secures the Risk Adjusted Performance of (0.03), mean deviation of 9.36, and Standard Deviation of 14.06. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mitesco, as well as the relationship between them.
Mitesco's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mitesco's valuation are provided below:
Mitesco does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Understanding that Mitesco's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mitesco represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Mitesco's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Mitesco 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mitesco's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mitesco.
0.00
11/03/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/01/2026
0.00
If you would invest  0.00  in Mitesco on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Mitesco or generate 0.0% return on investment in Mitesco over 90 days. Mitesco is related to or competes with Strainsforpains, and Invitro International. Mitesco, Inc. operates medical clinics under the The Good Clinic name in North East Minneapolis, the United States More

Mitesco Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mitesco's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mitesco upside and downside potential and time the market with a certain degree of confidence.

Mitesco Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Mitesco's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mitesco's standard deviation. In reality, there are many statistical measures that can use Mitesco historical prices to predict the future Mitesco's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mitesco's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0514.59
Details
Intrinsic
Valuation
LowRealHigh
0.000.0514.59
Details
Naive
Forecast
LowNextHigh
0.00030.0114.55
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.030.120.20
Details

Mitesco February 1, 2026 Technical Indicators

Mitesco Backtested Returns

Mitesco has Sharpe Ratio of -0.053, which conveys that the firm had a -0.053 % return per unit of risk over the last 3 months. Mitesco exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mitesco's Mean Deviation of 9.36, risk adjusted performance of (0.03), and Standard Deviation of 14.06 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.18, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mitesco will likely underperform. At this point, Mitesco has a negative expected return of -0.77%. Please make sure to verify Mitesco's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Mitesco performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.07  

Virtually no predictability

Mitesco has virtually no predictability. Overlapping area represents the amount of predictability between Mitesco time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mitesco price movement. The serial correlation of 0.07 indicates that barely 7.0% of current Mitesco price fluctuation can be explain by its past prices.
Correlation Coefficient0.07
Spearman Rank Test0.39
Residual Average0.0
Price Variance0.0
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Mitesco reported net income of (7.92 Million). This is 102.32% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The net income for all United States stocks is 101.39% higher than that of the company.

Mitesco Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mitesco's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Mitesco could also be used in its relative valuation, which is a method of valuing Mitesco by comparing valuation metrics of similar companies.
Mitesco is currently under evaluation in net income category among its peers.

Mitesco Fundamentals

About Mitesco Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Mitesco's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mitesco using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mitesco based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Mitesco Pink Sheet

Mitesco financial ratios help investors to determine whether Mitesco Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mitesco with respect to the benefits of owning Mitesco security.